Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc > That's the difference

<< Previous

Bullboard Posts

Next >>

Comment by NightHawk1987on May 17, 2020 10:54pm

104 Views

Post# 31041019

RE:RE:RE:RE:That's the difference

Seems like AMG is very knowledgeable and has been kicking this tire for years. A good asset to listen to. However, on the other board, I cant make heads or tails of what he's saying lol. His last post did not interpret well. Sounded like bashing of bloz which is irrelevant to AGN, but I couldn't make out if he was still positive on agn or not. The rant was incomprehensible to me. It seems you have followed him longer than me.... any help?

<< Previous

Bullboard Posts

Next >>

Infield Minerals to acquire Kings Canyon Gold Property